Garda Capital Partners LP - REGENERON PHARMACEUTICALS ownership

REGENERON PHARMACEUTICALS's ticker is and the CUSIP is 75886F907. A total of 12 filers reported holding REGENERON PHARMACEUTICALS in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Garda Capital Partners LP ownership history of REGENERON PHARMACEUTICALS
ValueSharesWeighting
Q3 2023$2,880,360
+133.7%
3,500
+133.3%
0.13%
+118.0%
Q1 2023$1,232,505
-77.2%
1,500
-80.0%
0.06%
-79.6%
Q4 2022$5,411,1757,5000.30%
Other shareholders
REGENERON PHARMACEUTICALS shareholders Q1 2023
NameSharesValueWeighting ↓
Garda Capital Partners LP 3,500$2,880,3600.13%
GROUP ONE TRADING, L.P. 31,900$26,252,4240.09%
SIMPLEX TRADING, LLC 33,500$27,5690.02%
IMC-Chicago, LLC 26,500$21,808,4400.02%
Allianz Asset Management GmbH 12,400$10,204,7040.02%
SG Americas Securities, LLC 16,700$1,1420.01%
JANE STREET GROUP, LLC 42,400$34,893,5040.01%
JPMORGAN CHASE & CO 32,900$27,075,3840.00%
Focused Wealth Management, Inc 400$12,4410.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of REGENERON PHARMACEUTICALS shareholders